Grants per year
- 1 - 25 out of 789 results
Search results
-
Active
Development of anti-LTBP4 as a biologic to treat Neuromuscular Diseases
Demonbreun, A. R. & McNally, E. M.
National Institute of Neurological Disorders and Stroke
6/16/22 → 5/31/24
Project: Research project
-
New roles of endothelial regrowth in ischemic tissue recovery and regeneration
National Heart, Lung, and Blood Institute
4/1/22 → 3/31/26
Project: Research project
-
Rapid Cardiovascular MRI for Screening Microvascular Angina in COVID-19 Survivors
Kim, D., Lee, D. C., Allen, B. D., Ison, M. G., Kalhan, R. & Markl, M.
4/1/22 → 3/31/25
Project: Research project
-
Measurement of ab-initio physiomarker using wearable sensors to predict aneurysm growth and formation
Pandit, J. A., Patankar, N. A. & Rogers, J. A.
3/21/22 → 3/20/23
Project: Research project
-
PEAKS Registry: Prospective Evaluation Analysis and Kinetics of IV Sotalol
University of Utah, AltaThera Pharmaceuticals, LLC
3/16/22 → 3/16/25
Project: Research project
-
Mac-Lab/CardioLab V8.0 System Performance Evaluation
Kim Koss, S. S. & Knight, B. P.
2/18/22 → 2/17/23
Project: Research project
-
CARDIALEN CL007: Novel Therapy System for Atrial Fibrillation
Cardialen, Inc., National Heart, Lung, and Blood Institute
2/1/22 → 8/31/22
Project: Research project
-
LUX-Dx Heart Failure Sensors in an Insertable Cardiac Monitor System Clinical Study
1/19/22 → 1/19/24
Project: Research project
-
PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study
Leipzig Heart Institute GmbH, European Commission
1/17/22 → 6/30/22
Project: Research project
-
Evolutionary advantage of heterozygous PAI-1 deficiency in humans
1/1/22 → 12/31/24
Project: Research project
-
Prot#D6402C00001: A Phase 2b, Randomised, Double-Blind, Placebo-Controlled, Multi-Centre Study to Evaluate the Efficacy, Safety and Tolerability of Oral AZD9977 and Dapagliflozin Treatment in Patients with Heart Failure with Left Ventricular Ejection Frac
Parexel, AstraZeneca Pharmaceuticals LP
12/21/21 → 12/21/24
Project: Research project
-
Prot#D6580C00010: A Randomised, Double-blind, Placebo-controlled, Multi-center Sequential Phase 2b and Phase 3 Study to Evaluate the Efficacy and Safety of AZD4831 Administered for up to 48 Weeks in Participants with Heart Failure With Left Ventricular Ej
AstraZeneca Pharmaceuticals LP
12/16/21 → 12/16/24
Project: Research project
-
Role of mRNA-binding protein tristetraprolin in cardiac mRNA regulation and the development of heart failure
National Heart, Lung, and Blood Institute
12/15/21 → 11/30/25
Project: Research project
-
-
PRegnancy OuTcomEs and subclinical Cardiovascular disease sTudy: (PROTECT)
Khan, S. S., Allen, N. B., Greenland, P., Grobman, W. A., Petito, L. C., Shah, S. J. & Welty, L. J.
National Heart, Lung, and Blood Institute
12/6/21 → 11/30/26
Project: Research project
-
Prot#AG10-304: An Open-Label Extension and Safety Monitoring Study of Acoramidis (AG10) in Participants with Symptomatic Transthyretin Amyloid Cardiomyopathy Who Completed the Phase 3 ATTRibute-CM Trial (AG10-301)
Pharmaceutical Research Associates, Inc., Eidos Therapeutics, Inc.
12/1/21 → 12/1/24
Project: Research project